Clinical Trial Update: Fractional Photothermolysis for Treating Melasma [NA]

View source ↗

Summary

A completed clinical trial evaluating fractional photothermolysis as a treatment for melasma, sponsored by Laserklinik Karlsruhe.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melasma

Snippet

Sponsor: Laserklinik Karlsruhe | Conditions: Melasma | NA | Status: COMPLETED